Candidate
Discovery Disc
Preclinical Preclin
Phase 1 Ph1
Phase 2 Ph2
Phase 3 Phase 3
Status status
Thyroid Eye Disease
Veligrotug Anti-IGF-1R
Veligrotug Anti-IGF-1R
BLA under priority review
Elegrobart Anti-IGF-1R
Elegrobart Anti-IGF-1R
Pivotal trials ongoing
Preclinical
Autoimmune Diseases
VRDN-006 Anti-FcRn
VRDN-006 Anti-FcRn
Phase 1 study ongoing
VRDN-008 Anti-FcRn
VRDN-008 Anti-FcRn
IND submitted